Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. Mevalonic acid lithium salt is effective in inhibiting Simvastatin -induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure. In Vitro Mevalonic acid lithium salt (80, 90, 100, 110 µM; 72 h) shows prevention of simvastatin-induced loss of viability of C2C12myotube cells in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: C2C12 cells (simvastatin-induced) Concentration: 80, 90, 100, 110 µM Incubation Time: 72 h Result: Showed no decline in cell viability. Form:Solid
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Mevalonic acid lithium salt
CAS number：2618458-93-6 molecular formula：C6H11LiO4
overview
compound introduction
Specs
| Chinese alias | 甲羟戊酸锂盐 | ||
| English alias | - | ||
| CAS number | 2618458-93-6 | molecular formula | C6H11LiO4 |
| molecular weight | 154.09 g/mol | Exact mass | ≥98% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
